BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34350518)

  • 1. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
    Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.
    van Turenhout ST; Oort FA; Terhaar sive Droste JS; Coupé VM; van der Hulst RW; Loffeld RJ; Scholten P; Depla AC; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG
    Gastrointest Endosc; 2012 Jul; 76(1):136-43. PubMed ID: 22726472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.
    Wassie MM; Young GP; Winter JM; Cock C; Bampton P; Rahman M; Heddle R; Fraser R; Meng R; Symonds EL
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2389-2398.e2. PubMed ID: 36610499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.
    O'Reilly SM; MacNally S; O'Donoghue D; Mooney T; Fitzpatrick P; Mulcahy HE; Cullen G
    Clin Transl Gastroenterol; 2021 Jan; 12(1):e00277. PubMed ID: 33512944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget Stool RNA Test for Colorectal Cancer Screening.
    Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
    JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.
    Nielson CM; Petrik AF; Jacob L; Vollmer WM; Keast EM; Schneider JL; Rivelli JS; Kapka TJ; Meenan RT; Mummadi RR; Green BB; Coronado GD
    Cancer Med; 2018 Sep; 7(9):4781-4790. PubMed ID: 30101513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management.
    Hsu WF; Cheng SY; Shun CT; Chang LC; Tu CH; Wang HP; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1738-1745. PubMed ID: 32187748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
    Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
    Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
    [No Abstract]   [Full Text] [Related]  

  • 18. Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
    Brenner H; Niedermaier T; Chen H
    Int J Cancer; 2017 May; 140(9):2015-2022. PubMed ID: 28152558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A True Positive and a False Negative? The Dilemma of Negative Colonoscopy After a Positive Fecal Occult Blood Test.
    Hunt JS; Cock C; Symonds EL
    Dig Dis Sci; 2022 May; 67(5):1843-1849. PubMed ID: 33939150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.